▶ 調査レポート

泌尿生殖器治療薬の世界市場(~2026年)

• 英文タイトル:Global Genitourinary Drugs Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。泌尿生殖器治療薬の世界市場(~2026年) / Global Genitourinary Drugs Market Size, Status and Forecast 2020-2026 / MRC2-11QY12028資料のイメージです。• レポートコード:MRC2-11QY12028
• 出版社/出版日:QYResearch / 2020年11月25日
• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥425,100 (USD3,900)▷ お問い合わせ
  Multi User¥637,650 (USD5,850)▷ お問い合わせ
  Enterprise License¥850,200 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は泌尿生殖器治療薬のグローバル市場について調査・分析したレポートです。種類別(泌尿器科、ホルモン療法、婦人科、抗感染薬)市場規模、用途別(前立腺がん、卵巣がん、膀胱がん、子宮頸がん、腎がん、勃起不全、尿路感染症、尿失禁・過活動膀胱、性感染症)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別泌尿生殖器治療薬の競争状況、市場シェア
・世界の泌尿生殖器治療薬市場:種類別市場規模 2015年-2020年(泌尿器科、ホルモン療法、婦人科、抗感染薬)
・世界の泌尿生殖器治療薬市場:種類別市場規模予測 2021年-2026年(泌尿器科、ホルモン療法、婦人科、抗感染薬)
・世界の泌尿生殖器治療薬市場:用途別市場規模 2015年-2020年(前立腺がん、卵巣がん、膀胱がん、子宮頸がん、腎がん、勃起不全、尿路感染症、尿失禁・過活動膀胱、性感染症)
・世界の泌尿生殖器治療薬市場:用途別市場規模予測 2021年-2026年(前立腺がん、卵巣がん、膀胱がん、子宮頸がん、腎がん、勃起不全、尿路感染症、尿失禁・過活動膀胱、性感染症)
・北米の泌尿生殖器治療薬市場分析:米国、カナダ
・ヨーロッパの泌尿生殖器治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの泌尿生殖器治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の泌尿生殖器治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの泌尿生殖器治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Novartis AG、Genentech
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases.
The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of pipeline drugs are expected to widen the scope for growth in the future.

Market Analysis and Insights: Global Genitourinary Drugs Market
The global Genitourinary Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Genitourinary Drugs Scope and Market Size
Genitourinary Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genitourinary Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Novartis AG
Genentech

Market segment by Type, the product can be split into
Urologicals
Hormonal Therapy
Gynecological
Anti-infectives
Market segment by Application, split into
Prostate Cancer
Ovarian Cancer
Bladder Cancer
Cervical Cancer
Renal Cancer
Erectile Dysfunction
Urinary Tract Infections
Urinary Incontinence & Overactive Bladder
Sexually Transmitted Diseases

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Genitourinary Drugs Revenue
1.4 Market by Type
1.4.1 Global Genitourinary Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Urologicals
1.4.3 Hormonal Therapy
1.4.4 Gynecological
1.4.5 Anti-infectives
1.5 Market by Application
1.5.1 Global Genitourinary Drugs Market Share by Application: 2020 VS 2026
1.5.2 Prostate Cancer
1.5.3 Ovarian Cancer
1.5.4 Bladder Cancer
1.5.5 Cervical Cancer
1.5.6 Renal Cancer
1.5.7 Erectile Dysfunction
1.5.8 Urinary Tract Infections
1.5.9 Urinary Incontinence & Overactive Bladder
1.5.10 Sexually Transmitted Diseases
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Genitourinary Drugs Market Perspective (2015-2026)
2.2 Global Genitourinary Drugs Growth Trends by Regions
2.2.1 Genitourinary Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Genitourinary Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Genitourinary Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Genitourinary Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Genitourinary Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Genitourinary Drugs Players by Market Size
3.1.1 Global Top Genitourinary Drugs Players by Revenue (2015-2020)
3.1.2 Global Genitourinary Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Genitourinary Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Genitourinary Drugs Market Concentration Ratio
3.2.1 Global Genitourinary Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Genitourinary Drugs Revenue in 2019
3.3 Genitourinary Drugs Key Players Head office and Area Served
3.4 Key Players Genitourinary Drugs Product Solution and Service
3.5 Date of Enter into Genitourinary Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Genitourinary Drugs Historic Market Size by Type (2015-2020)
4.2 Global Genitourinary Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Genitourinary Drugs Market Size by Application (2015-2020)
5.2 Global Genitourinary Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Genitourinary Drugs Market Size (2015-2020)
6.2 Genitourinary Drugs Key Players in North America (2019-2020)
6.3 North America Genitourinary Drugs Market Size by Type (2015-2020)
6.4 North America Genitourinary Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe Genitourinary Drugs Market Size (2015-2020)
7.2 Genitourinary Drugs Key Players in Europe (2019-2020)
7.3 Europe Genitourinary Drugs Market Size by Type (2015-2020)
7.4 Europe Genitourinary Drugs Market Size by Application (2015-2020)

8 China
8.1 China Genitourinary Drugs Market Size (2015-2020)
8.2 Genitourinary Drugs Key Players in China (2019-2020)
8.3 China Genitourinary Drugs Market Size by Type (2015-2020)
8.4 China Genitourinary Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan Genitourinary Drugs Market Size (2015-2020)
9.2 Genitourinary Drugs Key Players in Japan (2019-2020)
9.3 Japan Genitourinary Drugs Market Size by Type (2015-2020)
9.4 Japan Genitourinary Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Genitourinary Drugs Market Size (2015-2020)
10.2 Genitourinary Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Genitourinary Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Genitourinary Drugs Market Size by Application (2015-2020)

11 India
11.1 India Genitourinary Drugs Market Size (2015-2020)
11.2 Genitourinary Drugs Key Players in India (2019-2020)
11.3 India Genitourinary Drugs Market Size by Type (2015-2020)
11.4 India Genitourinary Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Genitourinary Drugs Market Size (2015-2020)
12.2 Genitourinary Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Genitourinary Drugs Market Size by Type (2015-2020)
12.4 Central & South America Genitourinary Drugs Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Novartis AG
13.1.1 Novartis AG Company Details
13.1.2 Novartis AG Business Overview
13.1.3 Novartis AG Genitourinary Drugs Introduction
13.1.4 Novartis AG Revenue in Genitourinary Drugs Business (2015-2020))
13.1.5 Novartis AG Recent Development
13.2 Genentech
13.2.1 Genentech Company Details
13.2.2 Genentech Business Overview
13.2.3 Genentech Genitourinary Drugs Introduction
13.2.4 Genentech Revenue in Genitourinary Drugs Business (2015-2020)
13.2.5 Genentech Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Genitourinary Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Genitourinary Drugs Revenue
Table 3. Ranking of Global Top Genitourinary Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Genitourinary Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Urologicals
Table 6. Key Players of Hormonal Therapy
Table 7. Key Players of Gynecological
Table 8. Key Players of Anti-infectives
Table 9. Global Genitourinary Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Genitourinary Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Genitourinary Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Genitourinary Drugs Market Share by Regions (2015-2020)
Table 13. Global Genitourinary Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Genitourinary Drugs Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Genitourinary Drugs Market Growth Strategy
Table 19. Main Points Interviewed from Key Genitourinary Drugs Players
Table 20. Global Genitourinary Drugs Revenue by Players (2015-2020) (Million US$)
Table 21. Global Genitourinary Drugs Market Share by Players (2015-2020)
Table 22. Global Top Genitourinary Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genitourinary Drugs as of 2019)
Table 23. Global Genitourinary Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Genitourinary Drugs Product Solution and Service
Table 26. Date of Enter into Genitourinary Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 29. Global Genitourinary Drugs Market Size Share by Type (2015-2020)
Table 30. Global Genitourinary Drugs Revenue Market Share by Type (2021-2026)
Table 31. Global Genitourinary Drugs Market Size Share by Application (2015-2020)
Table 32. Global Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 33. Global Genitourinary Drugs Market Size Share by Application (2021-2026)
Table 34. North America Key Players Genitourinary Drugs Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Genitourinary Drugs Market Share (2019-2020)
Table 36. North America Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 37. North America Genitourinary Drugs Market Share by Type (2015-2020)
Table 38. North America Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 39. North America Genitourinary Drugs Market Share by Application (2015-2020)
Table 40. Europe Key Players Genitourinary Drugs Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Genitourinary Drugs Market Share (2019-2020)
Table 42. Europe Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Genitourinary Drugs Market Share by Type (2015-2020)
Table 44. Europe Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Genitourinary Drugs Market Share by Application (2015-2020)
Table 46. China Key Players Genitourinary Drugs Revenue (2019-2020) (Million US$)
Table 47. China Key Players Genitourinary Drugs Market Share (2019-2020)
Table 48. China Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 49. China Genitourinary Drugs Market Share by Type (2015-2020)
Table 50. China Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 51. China Genitourinary Drugs Market Share by Application (2015-2020)
Table 52. Japan Key Players Genitourinary Drugs Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Genitourinary Drugs Market Share (2019-2020)
Table 54. Japan Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Genitourinary Drugs Market Share by Type (2015-2020)
Table 56. Japan Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Genitourinary Drugs Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Genitourinary Drugs Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Genitourinary Drugs Market Share (2019-2020)
Table 60. Southeast Asia Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Genitourinary Drugs Market Share by Type (2015-2020)
Table 62. Southeast Asia Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Genitourinary Drugs Market Share by Application (2015-2020)
Table 64. India Key Players Genitourinary Drugs Revenue (2019-2020) (Million US$)
Table 65. India Key Players Genitourinary Drugs Market Share (2019-2020)
Table 66. India Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 67. India Genitourinary Drugs Market Share by Type (2015-2020)
Table 68. India Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 69. India Genitourinary Drugs Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Genitourinary Drugs Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Genitourinary Drugs Market Share (2019-2020)
Table 72. Central & South America Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Genitourinary Drugs Market Share by Type (2015-2020)
Table 74. Central & South America Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Genitourinary Drugs Market Share by Application (2015-2020)
Table 76. Novartis AG Company Details
Table 77. Novartis AG Business Overview
Table 78. Novartis AG Product
Table 79. Novartis AG Revenue in Genitourinary Drugs Business (2015-2020) (Million US$)
Table 80. Novartis AG Recent Development
Table 81. Genentech Company Details
Table 82. Genentech Business Overview
Table 83. Genentech Product
Table 84. Genentech Revenue in Genitourinary Drugs Business (2015-2020) (Million US$)
Table 85. Genentech Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genitourinary Drugs Market Share by Type: 2020 VS 2026
Figure 2. Urologicals Features
Figure 3. Hormonal Therapy Features
Figure 4. Gynecological Features
Figure 5. Anti-infectives Features
Figure 6. Global Genitourinary Drugs Market Share by Application: 2020 VS 2026
Figure 7. Prostate Cancer Case Studies
Figure 8. Ovarian Cancer Case Studies
Figure 9. Bladder Cancer Case Studies
Figure 10. Cervical Cancer Case Studies
Figure 11. Renal Cancer Case Studies
Figure 12. Erectile Dysfunction Case Studies
Figure 13. Urinary Tract Infections Case Studies
Figure 14. Urinary Incontinence & Overactive Bladder Case Studies
Figure 15. Sexually Transmitted Diseases Case Studies
Figure 16. Genitourinary Drugs Report Years Considered
Figure 17. Global Genitourinary Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Genitourinary Drugs Market Share by Regions: 2020 VS 2026
Figure 19. Global Genitourinary Drugs Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Genitourinary Drugs Market Share by Players in 2019
Figure 22. Global Top Genitourinary Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genitourinary Drugs as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Genitourinary Drugs Revenue in 2019
Figure 24. North America Genitourinary Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Genitourinary Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Genitourinary Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Genitourinary Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Genitourinary Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Genitourinary Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Genitourinary Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed